CogniCann (cannabidiol/tetrahydrocannabinol) / Argent BioPharma, University of Notre Dame - LARVOL DELTA

MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer’s in the EU and UK (PRNewswire) - "MGC Pharmaceuticals Ltd...has signed an exclusive distribution agreement with Sciensus Rare, a part of UK health care group, Sciensus, for the distribution of CannEpil® and CogniCann® in key European territories and the UK. The agreement is for the distribution in key European territories and the UK for CannEpil®, used to treat Drug Resistant Epilepsy, and CogniCann®, used to treat patients with Dementia and Alzheimer's disease."

Licensing / partnership • Alzheimer's Disease • CNS Disorders • Epilepsy